v3.26.3
Significant agreements - Genentech Collaboration Agreement (Details)
3 Months Ended 9 Months Ended
Sep. 30, 2026
USD ($)
Sep. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Sep. 30, 2026
USD ($)
Sep. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
Dec. 31, 2024
USD ($)
Feb. 21, 2020
item
Significant agreements.                
Collaboration revenue $ 34,057,000 $ 11,734,000   $ 35,573,000 $ 24,631,000      
Deferred revenue 3,692,000     3,692,000   $ 38,469,000 $ 101,658,000  
Genentech                
Significant agreements.                
Number of potential development candidates | item               4
Collaboration revenue 0 6,537,000   0 $ 14,681,000      
Deferred revenue $ 0     $ 0   $ 0 $ 14,038,000  
Genentech | Material rights associated with the LSR Go Option for Collaboration Program One                
Significant agreements.                
Revenue recognized   $ 6,500,000            
Genentech | Collaboration Program 4 Performance Obligation                
Significant agreements.                
Revenue recognized     $ 7,500,000